Written Question · S1W-30879 · Session 1
What consideration is being given to allowing patients living in Edinburgh, Glasgow, Dundee and Aberdeen access to trials in experimental t…
The question
To ask the Scottish Executive what consideration is being given to allowing patients living in Edinburgh, Glasgow, Dundee and Aberdeen access to trials in experimental treatment and randomised controlled trials in the treatment of malignant brain tumours.
The answer
An additional £1 million has been made available to support the planned Scottish Cancer Research Network (SCRN) which is expected to at least double patient entry into clinical trials. The network is expected to be fully established by April 2003.Participation in clinical trials is subject to patient eligibility against preset research criteria and patient choice.
In the Official Report
No contribution in the Official Report cites S1W-30879 by reference.